Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Veracyte Inc (NASDAQ:VCYT)

6.37
Delayed Data
As of 4:00pm ET
 -0.07 / -1.09%
Today’s Change
5.75
Today|||52-Week Range
9.80
-17.70%
Year-to-Date
No recent news for Veracyte Inc.

Today’s Trading

Previous close6.44
Today’s open6.44
Day’s range6.09 - 6.61
Volume298,566
Average volume (3 months)146,542
Market cap$218.3M
Data as of 4:00pm ET, 12/13/2017

Growth & Valuation

Earnings growth (last year)+16.15%
Earnings growth (this year)+20.55%
Earnings growth (next 5 years)--
Revenue growth (last year)+31.48%
P/E ratioNM
Price/Sales3.43
Price/Book3.65

Competitors

 Today’s
change
Today’s
% change
CLDXCelldex Therapeutics...+0.04+1.36%
OXFDOxford Immunotec Glo...+0.27+2.04%
QTNTQuotient Ltd+0.01+0.23%
TRIBTrinity Biotech PLC0.000.00%
Data as of 4:00pm ET, 12/13/2017

Financials

Next reporting dateMarch 21, 2018
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$65.1M
Annual profit (last year)-$31.4M
Net profit margin-48.18%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Bonnie H. Anderson
President &
Chief Operating Officer
Christopher M. Hall
Corporate headquarters
South San Francisco, California

Forecasts